Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1557-1904

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo ; day:16 ; month:3 ; year:2020 ; pages:1-7
Journal of neuroImmune pharmacology ; (16.3.2020), 1-7

Creator: Ikezu, Tsuneya
Koro, Lacin
Wolozin, Benjamin
Farraye, Francis A.
Strongosky, Audrey J.
Wszolek, Zbigniew K.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11481-020-09909-8

URN: urn:nbn:de:101:1-2020052917391229912156

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ikezu, Tsuneya
Koro, Lacin
Wolozin, Benjamin
Farraye, Francis A.
Strongosky, Audrey J.
Wszolek, Zbigniew K.
SpringerLink (Online service)

Other Objects (12)

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32

The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast

Confocal laser endomicroscopy for characterization of Crohn’s disease-associated duodenitis

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Identification of Parkinson’s disease-associated chromatin regulators

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32

The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast

Confocal laser endomicroscopy for characterization of Crohn’s disease-associated duodenitis

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Identification of Parkinson’s disease-associated chromatin regulators

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32

The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast

Confocal laser endomicroscopy for characterization of Crohn’s disease-associated duodenitis

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Identification of Parkinson’s disease-associated chromatin regulators

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32

The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast

Confocal laser endomicroscopy for characterization of Crohn’s disease-associated duodenitis

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Identification of Parkinson’s disease-associated chromatin regulators

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32

The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast

Confocal laser endomicroscopy for characterization of Crohn’s disease-associated duodenitis

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Identification of Parkinson’s disease-associated chromatin regulators

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance

A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32

The enzymatic core of the Parkinson’s disease-associated protein LRRK2 impairs mitochondrial biogenesis in aging yeast

Confocal laser endomicroscopy for characterization of Crohn’s disease-associated duodenitis

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes

Identification of Parkinson’s disease-associated chromatin regulators

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Related objects

Reset password